The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Targeting natural killer cells and natural killer T cells in cancer
Open accessAbstract
Natural killer (NK) cells and natural killer T (NKT) cells are subsets of lymphocytes that share some phenotypical and functional similarities. Both cell types can rapidly respond to the presence of tumour cells and participate in antitumour immune responses. This has prompted interest in the development of innovative cancer therapies that are based on the manipulation of NK and NKT cells. Recent studies have highlighted how the immune reactivity of NK and NKT cells is shaped by the environment in which they develop. The rational use of these cells in cancer immunotherapies awaits a better understanding of their effector functions, migratory patterns and survival properties in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Szer, J. (1999) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127745.x · Cited by 3,353
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
Self-citationIn search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Ferrara, J. L., Levine, J. E., Reddy, P., & Holler, E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60237-3 · Cited by 2,464
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
Natural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., et al. (1998) · Blood · doi:10.1182/blood.v91.3.756 · Cited by 2,071
Kolb, H., Schattenberg, A., Goldman, J., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., & Niederwieser, D. (1995) · Blood · doi:10.1182/blood.v86.5.2041.bloodjournal8652041 · Cited by 1,934
Miller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,903
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Kiessling, R., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,824
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Bone-Marrow Transplantation: (First of Two Parts)
Thomas, E. D., Storb, R., Clift, R. A., Fefer, A., Johnson, F. L., Neiman, P. E., Lerner, K. G., Glucksberg, H., & Buckner, C. D. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504172921605 · Cited by 1,693
Adaptive immune features of natural killer cells
Sun, J. C., Beilke, J. N., & Lanier, L. L. (2009) · Nature · doi:10.1038/nature07665 · Cited by 1,619
Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts
Weiden, P. L., Flournoy, N., Thomas, E. D., Prentice, R., Fefer, A., Buckner, C. D., & Storb, R. (1979) · New England Journal of Medicine · doi:10.1056/nejm197905103001902 · Cited by 1,510
Herberman, R. B., Nunn, M. E., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160204 · Cited by 1,355
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Beutler, B. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.005 · Cited by 1,276
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.013 · Cited by 1,211
Self-citationMHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
Imai, K., Matsuyama, S., Miyake, S., Suga, K., & Nakachi, K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03231-1 · Cited by 1,190
Aversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391702 · Cited by 1,168
Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondón, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., et al. (1997) · Blood · doi:10.1182/blood.v89.12.4531 · Cited by 1,138
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
Mattner, J., DeBord, K. L., Ismail, N., Goff, R. D., Cantu, C., Zhou, D., Saint-Mezard, P., Wang, V., Gao, Y., Yin, N., et al. (2005) · Nature · doi:10.1038/nature03408 · Cited by 1,121
Lantz, O., & Bendelac, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1097 · Cited by 1,057
CD1: Antigen Presentation and T Cell Function
Brigl, M., & Brenner, M. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104608 · Cited by 1,035
TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and Paradoxes
Kronenberg, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115742 · Cited by 1,029
Childs, R., Chernoff, A., Contentin, N., Bahceci, E., Schrump, D., Leitman, S., Read, E. J., Tisdale, J., Dunbar, C., Linehan, W. M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009143431101 · Cited by 998
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
Lysosomal Glycosphingolipid Recognition by NKT Cells
Zhou, D., Mattner, J., Cantu, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y.-P., Yamashita, T., et al. (2004) · Science · doi:10.1126/science.1103440 · Cited by 956
T cell– and B cell–independent adaptive immunity mediated by natural killer cells
O'Leary, J. G., Goodarzi, M., Drayton, D. L., & von Andrian, U. H. (2006) · Nature Immunology · doi:10.1038/ni1332 · Cited by 919
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., & Phillips, J. H. (1998) · Nature · doi:10.1038/35642 · Cited by 904
Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C.-R., Koezuka, Y., & Kronenberg, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.741 · Cited by 887
Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H. (2000) · Nature Immunology · doi:10.1038/77793 · Cited by 878
Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Carnemolla, B., Cantoni, C., Grassi, J., Marcenaro, S., Reymond, N., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030788 · Cited by 875
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Miyamoto, K., Miyake, S., & Yamamura, T. (2001) · Nature · doi:10.1038/35097097 · Cited by 874
Carnaud, C., Lee, D., Donnars, O., Park, S.-H., Beavis, A., Koezuka, Y., & Bendelac, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4647 · Cited by 854
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Guerra, N., Tan, Y. X., Joncker, N. T., Choy, A., Gallardo, F., Xiong, N., Knoblaugh, S., Cado, D., Greenberg, N. R., & Raulet, D. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.016 · Cited by 850
Spits, H., & Di Santo, J. P. (2011) · Nature Immunology · doi:10.1038/ni.1962 · Cited by 842
Cytokine-induced memory-like natural killer cells
Cooper, M. A., Elliott, J. M., Keyel, P. A., Yang, L., Carrero, J. A., & Yokoyama, W. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813192106 · Cited by 831
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., & Godfrey, D. I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.661 · Cited by 829
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells
Karlhofer, F. M., Ribaudo, R. K., & Yokoyama, W. M. (1992) · Nature · doi:10.1038/358066a0 · Cited by 797
Porcelli, S., Yockey, C. E., Brenner, M. B., & Balk, S. P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.1 · Cited by 756
New aspects of natural-killer-cell surveillance and therapy of cancer
Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc928 · Cited by 752
Natural Killer Cell Signaling Pathways
Vivier, E., Nunès, J. A., & Vély, F. (2004) · Science · doi:10.1126/science.1103478 · Cited by 751
Self-citationVitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
The unconventional lifestyle of NKT cells
Kronenberg, M., & Gapin, L. (2002) · Nature Reviews Immunology · doi:10.1038/nri854 · Cited by 747
T-bet Regulates the Terminal Maturation and Homeostasis of NK and Vα14i NKT Cells
Townsend, M. J., Weinmann, A. S., Matsuda, J. L., Salomon, R., Farnham, P. J., Biron, C. A., Gapin, L., & Glimcher, L. H. (2004) · Immunity · doi:10.1016/s1074-7613(04)00076-7 · Cited by 722
The Transcription Factor PLZF Directs the Effector Program of the NKT Cell Lineage
Savage, A. K., Constantinides, M. G., Han, J., Picard, D., Martin, E., Li, B., Lantz, O., & Bendelac, A. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.011 · Cited by 716
Brandt, C. S., Baratin, M., Yi, E. C., Kennedy, J., Gao, Z., Fox, B., Haldeman, B., Ostrander, C. D., Kaifu, T., Chabannon, C., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090681 · Cited by 706
Self-citationNK cell development, homeostasis and function: parallels with CD8+ T cells
Sun, J. C., & Lanier, L. L. (2011) · Nature Reviews Immunology · doi:10.1038/nri3044 · Cited by 700
Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice
Cerwenka, A., Bakker, A. B. H., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)80222-8 · Cited by 695
Paust, S., Gill, H. S., Wang, B.-Z., Flynn, M. P., Moseman, E. A., Senman, B., Szczepanik, M., Telenti, A., Askenase, P. W., Compans, R. W., et al. (2010) · Nature Immunology · doi:10.1038/ni.1953 · Cited by 694
Mechanism of CD1d-restricted natural killer T cell activation during microbial infection
Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E., & Brenner, M. B. (2003) · Nature Immunology · doi:10.1038/ni1002 · Cited by 672
Stetson, D. B., Mohrs, M., Reinhardt, R. L., Baron, J. L., Wang, Z.-E., Gapin, L., Kronenberg, M., & Locksley, R. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030630 · Cited by 617
Ruggeri, L., Mancusi, A., Capanni, M., Urbani, E., Carotti, A., Aloisi, T., Stern, M., Pende, D., Perruccio, K., Burchielli, E., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038687 · Cited by 616
Tilloy, F., Treiner, E., Park, S.-H., Garcia, C., Lemonnier, F., de la Salle, H., Bendelac, A., Bonneville, M., & Lantz, O. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1907 · Cited by 615
Recruitment of Tyrosine Phosphatase HCP by the Killer Cell Inhibitory Receptor
Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J.-P., & Long, E. O. (1996) · Immunity · doi:10.1016/s1074-7613(00)80300-3 · Cited by 613
Self-tolerance of natural killer cells
Raulet, D. H., & Vance, R. E. (2006) · Nature Reviews Immunology · doi:10.1038/nri1863 · Cited by 608
Natural killer cells act as rheostats modulating antiviral T cells
Waggoner, S. N., Cornberg, M., Selin, L. K., & Welsh, R. M. (2012) · Nature · doi:10.1038/nature10624 · Cited by 607
Fernandez, N. C., Treiner, E., Vance, R. E., Jamieson, A. M., Lemieux, S., & Raulet, D. H. (2005) · Blood · doi:10.1182/blood-2004-08-3156 · Cited by 588
Holler, E., Kolb, H., Moller, A., Kempeni, J., Liesenfeld, S., Pechumer, H., Lehmacher, W., Ruckdeschel, G., Gleixner, B., & Riedner, C. (1990) · Blood · doi:10.1182/blood.v75.4.1011.1011 · Cited by 577
Kovalovsky, D., Uche, O. U., Eladad, S., Hobbs, R. M., Yi, W., Alonzo, E., Chua, K., Eidson, M., Kim, H.-J., Im, J. S., et al. (2008) · Nature Immunology · doi:10.1038/ni.1641 · Cited by 557
In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers
Benlagha, K., Weiss, A., Beavis, A., Teyton, L., & Bendelac, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1895 · Cited by 556
p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., & Moretta, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1129 · Cited by 554
Giebel, S. (2003) · Blood · doi:10.1182/blood-2003-01-0091 · Cited by 549
A Thymic Precursor to the NK T Cell Lineage
Benlagha, K., Kyin, T., Beavis, A., Teyton, L., & Bendelac, A. (2002) · Science · doi:10.1126/science.1069017 · Cited by 519
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Platonova, S., Cherfils-Vicini, J., Damotte, D., Crozet, L., Vieillard, V., Validire, P., André, P., Dieu-Nosjean, M.-C., Alifano, M., Régnard, J.-F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4179 · Cited by 512
Giaccone, G., Punt, C. J. A., Ando, Y., Ruijter, R., Nishi, N., Peters, M. E. W. J., Blomberg, B. M. E. V., Scheper, R. J., van der Vliet, H. J., van den Eertwegh, A. J. M., et al. (2002) · PubMed · Cited by 506
Hermans, I. F., Silk, J. D., Gileadi, U., Salio, M., Mathew, B., Ritter, G., Schmidt, R., Harris, A. L., Old, L., & Cerundolo, V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5140 · Cited by 492
MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity
Liao, N.-S., Bix, M., Zijlstra, M., Jaenisch, R., & Raulet, D. (1991) · Science · doi:10.1126/science.1853205 · Cited by 490
Vance, R. E., Kraft, J. R., Altman, J. D., Jensen, P. E., & Raulet, D. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1841 · Cited by 482
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5690 · Cited by 476
Soriani, A., Zingoni, A., Cerboni, C., Iannitto, M. L., Ricciardi, M. R., Di Gialleonardo, V., Cippitelli, M., Fionda, C., Petrucci, M. T., Guarini, A., et al. (2009) · Blood · doi:10.1182/blood-2008-08-173914 · Cited by 460
Glycolipid antigen induces long-term natural killer T cell anergy in mice
Parekh, V. V. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24762 · Cited by 458
Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., & Moretta, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.875 · Cited by 447
The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development
Gascoyne, D. M., Long, E., Veiga-Fernandes, H., de Boer, J., Williams, O., Seddon, B., Coles, M., Kioussis, D., & Brady, H. J. M. (2009) · Nature Immunology · doi:10.1038/ni.1787 · Cited by 447
Natural Killer Cell Education and Tolerance
Orr, M. T., & Lanier, L. L. (2010) · Cell · doi:10.1016/j.cell.2010.08.031 · Cited by 441
Geller, M. A., Cooley, S., Judson, P. L., Ghebre, R., Carson, L. F., Argenta, P. A., Jonson, A. L., Panoskaltsis-Mortari, A., Curtsinger, J., McKenna, D., et al. (2011) · Cytotherapy · doi:10.3109/14653249.2010.515582 · Cited by 436
NKT cells derive from double-positive thymocytes that are positively selected by CD1d
Gapin, L., Matsuda, J. L., Surh, C. D., & Kronenberg, M. (2001) · Nature Immunology · doi:10.1038/ni710 · Cited by 435
Arai, S., Meagher, R., Swearingen, M., Myint, H., Rich, E., Martinson, J., & Klingemann, H. (2008) · Cytotherapy · doi:10.1080/14653240802301872 · Cited by 434
Chang, D. H., Osman, K., Connolly, J., Kukreja, A., Krasovsky, J., Pack, M., Hutchinson, A., Geller, M., Liu, N., Annable, R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042592 · Cited by 415
Romagné, F., André, P., Spee, P., Zahn, S., Anfossi, N., Gauthier, L., Capanni, M., Ruggeri, L., Benson, D. M., Blaser, B. W., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206532 · Cited by 408
Self-citationCurti, A., Ruggeri, L., D'Addio, A., Bontadini, A., Dan, E., Motta, M. R., Trabanelli, S., Giudice, V., Urbani, E., Martinelli, G., et al. (2011) · Blood · doi:10.1182/blood-2011-01-329508 · Cited by 406
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
Raulet, D. H., & Guerra, N. (2009) · Nature Reviews Immunology · doi:10.1038/nri2604 · Cited by 404
Ishikawa, A., Motohashi, S., Ishikawa, E., Fuchida, H., Higashino, K., Otsuji, M., Iizasa, T., Nakayama, T., Taniguchi, M., & Fujisawa, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1453 · Cited by 403
Smyth, M. J., Crowe, N. Y., Pellicci, D. G., Kyparissoudis, K., Kelly, J. M., Takeda, K., Yagita, H., & Godfrey, D. I. (2002) · Blood · doi:10.1182/blood.v99.4.1259 · Cited by 392
Loss of IFN-γ Production by Invariant NK T Cells in Advanced Cancer
Muhammad Ali Tahir, S., Cheng, O., Shaulov, A., Koezuka, Y., Bubley, G. J., Wilson, S. B., Balk, S. P., & Exley, M. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.4046 · Cited by 386
Schmieg, J., Yang, G., Franck, R. W., & Tsuji, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031192 · Cited by 385
Burdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., Taniguchi, M., Hayakawa, K., & Kronenberg, M. (1998) · PubMed · Cited by 381
Self-citationCarrega, P., Morandi, B., Costa, R., Frumento, G., Forte, G., Altavilla, G., Ratto, G. B., Mingari, M. C., Moretta, L., & Ferlazzo, G. (2008) · Cancer · doi:10.1002/cncr.23239 · Cited by 379
Pende, D., Marcenaro, S., Falco, M., Martini, S., Bernardo, M. E., Montagna, D., Romeo, E., Cognet, C., Martinetti, M., Maccario, R., et al. (2009) · Blood · doi:10.1182/blood-2008-06-164103 · Cited by 378
Self-citationPellicci, D. G., Hammond, K. J. L., Uldrich, A. P., Baxter, A. G., Smyth, M. J., & Godfrey, D. I. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011544 · Cited by 371
Nieda, M., Okai, M., Tazbirkova, A., Lin, H., Yamaura, A., Ide, K., Abraham, R., Juji, T., Macfarlane, D. J., & Nicol, A. J. (2004) · Blood · doi:10.1182/blood-2003-04-1155 · Cited by 361
Olcese, L., Lang, P., Vély, F., Cambiaggi, A., Marguet, D., Bléry, M., Hippen, K. L., Biassoni, R., Moretta, A., Moretta, L., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4531 · Cited by 360
Self-citationCrowe, N. Y., Smyth, M. J., & Godfrey, D. I. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020092 · Cited by 352
Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
Song, L., Asgharzadeh, S., Salo, J., Engell, K., Wu, H.-W., Sposto, R., Ara, T., Silverman, A. M., DeClerck, Y. A., Seeger, R. C., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37869 · Cited by 342
Modulation of CD1d-restricted NKT cell responses by using N- acyl variants of α-galactosylceramides
Yu, K. O. A., Im, J. S., Molano, A., Dutronc, Y., Illarionov, P. A., Forestier, C., Fujiwara, N., Arias, I., Miyake, S., Yamamura, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407488102 · Cited by 337
Burdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., Taniguchi, M., Hayakawa, K., & Kronenberg, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3271 · Cited by 334
Self-citationNfil3/E4bp4 is required for the development and maturation of NK cells in vivo
Kamizono, S., Duncan, G. S., Seidel, M. G., Morimoto, A., Hamada, K., Grosveld, G., Akashi, K., Lind, E. F., Haight, J. P., Ohashi, P. S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20092176 · Cited by 334
Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
Eberl, G., & MacDonald, H. R. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200004)30:4<985::aid-immu985>3.0.co;2-e · Cited by 326
Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals
Brennan, P. J., Tatituri, R. V. V., Brigl, M., Kim, E. Y., Tuli, A., Sanderson, J. P., Gadola, S. D., Hsu, F.-F., Besra, G. S., & Brenner, M. B. (2011) · Nature Immunology · doi:10.1038/ni.2143 · Cited by 326
Natural killer cells in human health and disease
Orange, J. S., & Ballas, Z. K. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.10.011 · Cited by 318
Halama, N., Braun, M., Kahlert, C., Spille, A., Quack, C., Rahbari, N., Koch, M., Weitz, J., Kloor, M., Zoernig, I., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2173 · Cited by 300
Homeostasis of Vα14i NKT cells
Matsuda, J. L., Gapin, L., Sidobre, S., Kieper, W. C., Tan, J. T., Ceredig, R., Surh, C. D., & Kronenberg, M. (2002) · Nature Immunology · doi:10.1038/ni837 · Cited by 299
Tachibana, T., Onodera, H., Tsuruyama, T., Mori, A., Nagayama, S., Hiai, H., & Imamura, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0877 · Cited by 295
Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E., & Raulet, D. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803900 · Cited by 291
Self-citationNatural killer cell–directed therapies: moving from unexpected results to successful strategies
Terme, M., Ullrich, E., Delahaye, N. F., Chaput, N., & Zitvogel, L. (2008) · Nature Immunology · doi:10.1038/ni1580 · Cited by 289
NK cell education: not an on-off switch but a tunable rheostat
Brodin, P., Kärre, K., & Höglund, P. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.01.006 · Cited by 288
Cancer immunology—analysis of host and tumor factors for personalized medicine
Ogino, S., Galon, J., Fuchs, C. S., & Dranoff, G. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.122 · Cited by 284
Terabe, M., Swann, J., Ambrosino, E., Sinha, P., Takaku, S., Hayakawa, Y., Godfrey, D. I., Ostrand-Rosenberg, S., Smyth, M. J., & Berzofsky, J. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051381 · Cited by 283
Brigl, M., Tatituri, R. V. V., Watts, G. F. M., Bhowruth, V., Leadbetter, E. A., Barton, N., Cohen, N. R., Hsu, F.-F., Besra, G. S., & Brenner, M. B. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102555 · Cited by 281
Brodin, P., Lakshmikanth, T., Johansson, S., Kärre, K., & Höglund, P. (2009) · Blood · doi:10.1182/blood-2008-05-156836 · Cited by 279
Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells
Wu, D. Y., Segal, N. H., Sidobre, S., Kronenberg, M., & Chapman, P. B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030446 · Cited by 279
Paget, C., Mallevaey, T., Speak, A. O., Torres, D., Fontaine, J., Sheehan, K. C. F., Capron, M., Ryffel, B., Faveeuw, C., Leite de Moraes, M., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.017 · Cited by 276
'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection
Orr, M. T., Murphy, W. J., & Lanier, L. L. (2010) · Nature Immunology · doi:10.1038/ni.1849 · Cited by 276
Höglund, P., Ohlén, C., Carbone, E., Franksson, L., Ljunggren, H. G., Latour, A., Koller, B., & Kärre, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10332 · Cited by 271
Passweg, J. R., Tichelli, A., Meyer-Monard, S., Heim, D., Stern, M., Kühne, T., Favre, G., & Gratwohl, A. (2004) · Leukemia · doi:10.1038/sj.leu.2403524 · Cited by 270
Egawa, T., Eberl, G., Taniuchi, I., Benlagha, K., Geissmann, F., Hennighausen, L., Bendelac, A., & Littman, D. R. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.011 · Cited by 270
Dazzi, F., Szydlo, R., Cross, N. C. P., Craddock, C., Kaeda, J., Kanfer, E., Cwynarski, K., Olavarría, E., Yong, A. S. M., Apperley, J. F., et al. (2000) · Blood · doi:10.1182/blood.v96.8.2712 · Cited by 267
Olcese, L., Cambiaggi, A., Semenzato, G., Bottino, C., Moretta, A., & Vivier, E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5083 · Cited by 262
Self-citationMature natural killer cells reset their responsiveness when exposed to an altered MHC environment
Joncker, N. T., Shifrin, N., Delebecque, F., & Raulet, D. H. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100570 · Cited by 259
Motohashi, S., Ishikawa, A., Ishikawa, E., Otsuji, M., Iizasa, T., Hanaoka, H., Shimizu, N., Horiguchi, S., Okamoto, Y., Fujii, S.-I., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0114 · Cited by 239
Invariant NKT cells sustain specific B cell responses and memory
Galli, G., Pittoni, P., Tonti, E., Malzone, C., Uematsu, Y., Tortoli, M., Maione, D., Volpini, G., Finco, O., Nuti, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700191104 · Cited by 237
Oki, S., Chiba, A., Yamamura, T., & Miyake, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420862 · Cited by 232
Elliott, J. M., Wahle, J. A., & Yokoyama, W. M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100986 · Cited by 225
Marks, D. I. (2002) · Blood · doi:10.1182/blood-2002-02-0506 · Cited by 216
CD169+ macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes
Barral, P., Polzella, P., Bruckbauer, A., van Rooijen, N., Besra, G. S., Cerundolo, V., & Batista, F. D. (2010) · Nature Immunology · doi:10.1038/ni.1853 · Cited by 215
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
Andrews, D. M., Estcourt, M. J., Andoniou, C. E., Wikstrom, M. E., Khong, A., Voigt, V., Fleming, P., Tabarias, H., Hill, G. R., van der Most, R. G., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091193 · Cited by 215
Barral, P., Eckl-Dorna, J., Harwood, N. E., De Santo, C., Salio, M., Illarionov, P., Besra, G. S., Cerundolo, V., & Batista, F. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802968105 · Cited by 211
Benson, D. M., Bakan, C. E., Zhang, S., Collins, S. M., Liang, J., Srivastava, S., Hofmeister, C. C., Efebera, Y., Andre, P., Romagne, F., et al. (2011) · Blood · doi:10.1182/blood-2011-06-360255 · Cited by 208
How Do Natural Killer Cells Find Self to Achieve Tolerance?
Yokoyama, W. M., & Kim, S. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.006 · Cited by 206
Ménard, C., Blay, J.-Y., Borg, C., Michiels, S., Ghiringhelli, F., Robert, C., Nonn, C., Chaput, N., Taïeb, J., Delahaye, N. F., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3807 · Cited by 202
Savani, B. N., Mielke, S., Adams, S., Uribe, M., Rezvani, K., Yong, A. S. M., Zeilah, J., Kurlander, R., Srinivasan, R., Childs, R., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404892 · Cited by 196
Shi, J., Tricot, G., Szmania, S., Rosen, N., Garg, T. K., Malaviarachchi, P. A., Moreno, A., DuPont, B., Hsu, K. C., Baxter‐Lowe, L. A., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07340.x · Cited by 194
Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation
Salio, M., Speak, A. O., Shepherd, D., Polzella, P., Illarionov, P. A., Veerapen, N., Besra, G. S., Platt, F. M., & Cerundolo, V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710145104 · Cited by 192
A new self: MHC-class-I-independent Natural-killer-cell self-tolerance
Kumar, V., & McNerney, M. E. (2005) · Nature Reviews Immunology · doi:10.1038/nri1603 · Cited by 187
Kunii, N., Horiguchi, S., Motohashi, S., Yamamoto, H., Ueno, N., Yamamoto, S., Sakurai, D., Taniguchi, M., Nakayama, T., & Okamoto, Y. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01135.x · Cited by 184
Yamasaki, K., Horiguchi, S., Kurosaki, M., Kunii, N., Nagato, K., Hanaoka, H., Shimizu, N., Ueno, N., Yamamoto, S., Taniguchi, M., et al. (2011) · Clinical Immunology · doi:10.1016/j.clim.2010.11.014 · Cited by 183
Cutting Edge: The Mechanism of Invariant NKT Cell Responses to Viral Danger Signals
Tyznik, A. J., Tupin, E., Nagarajan, N. A., Her, M. J., Benedict, C. A., & Kronenberg, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4452 · Cited by 179
Allogeneic natural killer cells for refractory lymphoma
Bachanova, V., Burns, L. J., McKenna, D. H., Curtsinger, J., Panoskaltsis-Mortari, A., Lindgren, B. R., Cooley, S., Weisdorf, D., & Miller, J. S. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-010-0896-z · Cited by 177
Renukaradhya, G. J., Khan, M. A., Vieira, M., Du, W., Gervay-Hague, J., & Brutkiewicz, R. R. (2008) · Blood · doi:10.1182/blood-2007-05-092866 · Cited by 168
Shimizu, K., Kurosawa, Y., Taniguchi, M., Steinman, R. M., & Fujii, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070458 · Cited by 165
Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells
Metelitsa, L. S., Weinberg, K. I., Emanuel, P. D., & Seeger, R. C. (2003) · Leukemia · doi:10.1038/sj.leu.2402943 · Cited by 163
Natural killer cells in human autoimmune diseases
Schleinitz, N., Vély, F., Harlé, J., & Vivier, E. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03360.x · Cited by 158
Self-citationVerheyden, S., Schots, R., Duquet, W., & Demanet, C. (2005) · Leukemia · doi:10.1038/sj.leu.2403839 · Cited by 148
IL-15 availability conditions homeostasis of peripheral natural killer T cells
Ranson, T., Vosshenrich, C. A. J., Corcuff, E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0535482100 · Cited by 146
Confinement of Activating Receptors at the Plasma Membrane Controls Natural Killer Cell Tolerance
Guia, S., Jaeger, B. N., Piatek, S., Mailfert, S., Trombik, T., Fenis, A., Chevrier, N., Walzer, T., Kerdiles, Y. M., Marguet, D., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001608 · Cited by 146
Self-citationLi, Y., Wang, Q., & Mariuzza, R. A. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20102548 · Cited by 144
Dong, Z., Cruz‐Munoz, M., Zhong, M., Chen, R., Latour, S., & Veillette, A. (2009) · Nature Immunology · doi:10.1038/ni.1763 · Cited by 142
Eckl, J., Büchner, A., Prinz, P. U., Riesenberg, R., Siegert, S. I., Kammerer, R., Nelson, P. J., & Noeßner, E. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0806-7 · Cited by 142
McQueen, K. L., Dorighi, K. M., Guethlein, L. A., Wong, R. M., Sanjanwala, B. M., & Parham, P. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.01.019 · Cited by 141
Wang, H., Grzywacz, B. J., Sukovich, D. J., McCullar, V., Cao, Q., Lee‐Sherick, A. B., Blazar, B. R., Cornfield, D. N., Miller, J. S., & Verneris, M. R. (2007) · Blood · doi:10.1182/blood-2006-10-048173 · Cited by 139
Wingender, G., Krebs, P., Beutler, B., & Kronenberg, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001018 · Cited by 138
Veeramani, S., Wang, S., Dahle, C. E., Blackwell, S. E., Jacobus, L., Knutson, T. M., Button, A. M., Link, B. K., & Weiner, G. J. (2011) · Blood · doi:10.1182/blood-2011-05-351411 · Cited by 132
The Vα14 NKT Cell TCR Exhibits High-Affinity Binding to a Glycolipid/CD1d Complex
Sidobre, S., Naidenko, O. V., Sim, B.-C., Gascoigne, N. R. J., García, K. C., & Kronenberg, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1340 · Cited by 132
Impaired Proliferative Response of Vα24 NKT Cells from Cancer Patients Against α-Galactosylceramide
Yanagisawa, K., Seino, K., Ishikawa, Y., Nozue, M., Todoroki, T., & Fukao, K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6494 · Cited by 131
Lipid and glycolipid antigens of CD1d-restricted natural killer T cells
Venkataswamy, M. M., & Porcelli, S. A. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.10.003 · Cited by 129
How to recongnize a foreign submarine
Kärre, K. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00935.x · Cited by 127
Type I natural killer T cells suppress tumors caused by p53 loss in mice
Swann, J. B., Uldrich, A. P., van Dommelen, S. L. H., Sharkey, J., Murray, W. K., Godfrey, D. I., & Smyth, M. J. (2009) · Blood · doi:10.1182/blood-2009-01-198564 · Cited by 126
Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors
Pellicci, D. G., Clarke, A., Patel, O., Mallevaey, T., Beddoe, T., Nours, J. L., Uldrich, A. P., McCluskey, J., Besra, G. S., Porcelli, S. A., et al. (2011) · Nature Immunology · doi:10.1038/ni.2076 · Cited by 126
Chen, C., Busson, M., Rocha, V., Appert, M.-L., Lepage, V., Dulphy, N., Haas, P., Socié, G., Toubert, A., Charron, D. J., et al. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705468 · Cited by 123
Blaise, D. (2003) · Blood · doi:10.1182/blood-2003-07-2236 · Cited by 123
Self-citationNK Cell–Like Behavior of Vα14i NK T Cells during MCMV Infection
Wesley, J. D., Tessmer, M. S., Chaukos, D. C., & Brossay, L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000106 · Cited by 122
Self-citationMechanisms for Glycolipid Antigen-Driven Cytokine Polarization by Vα14 i NKT Cells
Sullivan, B. A., Nagarajan, N. A., Wingender, G., Wang, J., Scott, I., Tsuji, M., Franck, R. W., Porcelli, S. A., Zajonc, D. M., & Kronenberg, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902880 · Cited by 121
McKenna, D. H., Sumstad, D., Bostrom, N., Kadidlo, D. M., Fautsch, S. K., McNearney, S. A., DeWaard, R., McGlave, P. B., Weisdorf, D. J., Wagner, J. E., et al. (2007) · Transfusion · doi:10.1111/j.1537-2995.2006.01145.x · Cited by 117
Kröger, N. M., Shaw, B. E., Iacobelli, S., Zabelina, T., Peggs, K. S., Shimoni, A., Nagler, A., Binder, T. M., EIERMANN, T. H., Madrigal, J. A., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05513.x · Cited by 117
EXPANSION AND ACTIVATION OF NATURAL KILLER CELLS FOR CANCER IMMUNOTHERAPY
Cho, D., & Campana, D. (2009) · The Korean Journal of Laboratory Medicine · doi:10.3343/kjlm.2009.29.2.89 · Cited by 113
Hix, L. M., Shi, Y. H., Brutkiewicz, R. R., Stein, P. L., Wang, C.-R., & Zhang, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020702 · Cited by 107
Guo, M., Hu, K., Yu, C., Sun, Q., Qiao, J., Wang, D., Liu, G.-X., Sun, W.-J., Wei, L., Sun, X., et al. (2010) · Blood · doi:10.1182/blood-2010-06-288506 · Cited by 106
Evolution of the Ly49 and Nkrp1 recognition systems
Carlyle, J. R., Mesci, A., Fine, J. H., Chen, P., Bélanger, S., Tai, L., & Makrigiannis, A. P. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.05.004 · Cited by 105
Wei, D. G., Curran, S. A., Savage, P. B., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060418 · Cited by 98
Exley, M. A., Hou, R., Shaulov, A., Tonti, E., Dellabona, P., Casorati, G., Akbari, O., Akman, H. O., Greenfield, E. A., Gumperz, J. E., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737389 · Cited by 98
Brehm, C., Huenecke, S., Quaiser, A., Esser, R., Bremm, M., Kloeß, S., Soerensen, J., Kreyenberg, H., Seidl, C., Becker, P. S. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027351 · Cited by 93
Schneiders, F. L., Scheper, R. J., von Blomberg, B. M. E., et al. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.11.010 · Cited by 93
The Role of Natural Killer Cells in Sepsis
Chiche, L., Forel, J.-M., Thomas, G., Farnarier, C., Vely, F., Bléry, M., Papazian, L., & Vivier, É. (2011) · BioMed Research International · doi:10.1155/2011/986491 · Cited by 92
Lundqvist, A., McCoy, J. P., Samsel, L., & Childs, R. W. (2006) · Blood · doi:10.1182/blood-2006-05-024315 · Cited by 91
Clausen, J., Wolf, D. G. F., Petzer, A. L., Gunsilius, E., Schumacher, P., Kircher, B., Gastl, G. A., & Nachbaur, D. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03360.x · Cited by 86
Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
Unni, A. M., Bondar, T., & Medzhitov, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701675105 · Cited by 85
Cantu, C., Benlagha, K., Savage, P. B., Bendelac, A. S., & Teyton, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4673 · Cited by 85
Stanic, A. K., Shashidharamurthy, R., Bezbradica, J. S., Matsuki, N., Yoshimura, Y., Miyake, S., Choi, E. Y., Schell, T. D., Kaer, L. V., Tevethia, S. S., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4539 · Cited by 84
de Santis, D., Bishara, A., Witt, C., Nagler, A., Brautbar, C., Slavin, S., & Christiansen, F. (2005) · Tissue Antigens · doi:10.1111/j.1399-0039.2005.00396.x · Cited by 82
Blaise, D., Vey, N., Faucher, C., & Mohty, M. (2007) · Haematologica · doi:10.3324/haematol.10867 · Cited by 80
Self-citationNowak, M. D., Arredouani, M., Tun-Kyi, A., Schmidt-Wolf, I., Sanda, M., Balk, S., & Exley, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011311 · Cited by 80
CD1-Restricted T Cells and Tumor Immunity
Swann, J. B., Coquet, J. M., Smyth, M. J., & Godfrey, D. I. (2007) · Springer eBooks · doi:10.1007/978-3-540-69511-0_12 · Cited by 79
Ligands for murine NKG2D display heterogeneous binding behavior
Carayannopoulos, L. N., Naidenko, O. V., Kinder, J. M., Ho, E. L., Fremont, D. H., & Yokoyama, W. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<597::aid-immu597>3.0.co;2-e · Cited by 79
Cited by
The biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., Agdashian, D., Terabe, M., Berzofsky, J. A., Fako, V., et al. (2018) · Science · doi:10.1126/science.aan5931 · Cited by 1,508
Arneth, B. (2019) · Medicina · doi:10.3390/medicina56010015 · Cited by 1,250
André, P., Denis, C., Soulas, C., Bourbon-Caillet, C., Lopez, J., Arnoux, T., Bléry, M., Bonnafous, C., Gauthier, L., Morel, A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.014 · Cited by 1,221
Self-citationDai, Y., Xu, C., Sun, X., & Chen, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 931
Metadata
- Authors
- Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L.
- Venue
- Nature Reviews Immunology
- Published
- 2012-03-22
- Volume
- 12
- Issue
- 4
- Pages
- 239-252
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2065202184
- Cited by
- 850
- References
- 220
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.